SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Sep 12, 2019
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Sept. 12, 2019 · CIK: 0001711786 · Accession: 0001213900-19-017814
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233563
Letter
Hoth Therapeutics, Inc.
1 Rockefeller Plaza, Suite 1039
New York, New York 10020
September 12, 2019
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor
Re: Hoth Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-233563
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Hoth Therapeutics, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Time, on Friday September 13, 2019, or as soon thereafter as possible.
Please notify Nazia Khan of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8179 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
HOTH THERAPEUTICS, INC.
By: /s/ Robb Knie
Name: Robb Knie
Title: Chief Executive Officer
Show Raw Text
CORRESP
1
filename1.htm
Hoth Therapeutics, Inc.
1 Rockefeller Plaza, Suite 1039
New York, New York 10020
September 12, 2019
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor
Re:
Hoth Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-233563
Ladies and Gentlemen:
Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Hoth Therapeutics,
Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above
be accelerated so that it will become effective at 5:00 p.m., Eastern Time, on Friday September 13, 2019, or as soon thereafter
as possible.
Please notify Nazia Khan
of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8179 as soon as possible as to the time
the Registration Statement has been declared effective pursuant to this acceleration request.
HOTH THERAPEUTICS, INC.
By:
/s/ Robb Knie
Name:
Robb Knie
Title:
Chief Executive Officer